Issue Date | Title | Author(s) |
2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
2009-10-20 | Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer | Arndt, GM; Dossey, L; Cullen, LM; Lai, A; Druker, R; Eisbacher, M; Zhang, C; Tran, N; Fan, H; Retzlaff, K; Bittner, A; Raponi, M |
2024-04 | FDA-approved disulfiram as a novel treatment for aggressive leukemia. | Karsa, M; Xiao, L; Ronca, E; Bongers, A; Spurling, D; Karsa, A; Cantilena, S; Mariana, A; Failes, TW; Arndt, GM; Cheung, LC; Kotecha, RS; Sutton, R; Lock, RB; Williams, O; de Boer, J; Haber, M; Norris, MD; Henderson, MJ; Somers, K |
2009-01 | RNA modulators of complex phenotypes in mammalian cells | Lai, A; Cairns, MJ; Tran, NT; Zhang, H; Cullen, L; Arndt, GM |